Rutgers geneticist Linda Brzustowicz and her colleagues have identified a specific DNA change that is likely to increase risk for developing schizophrenia in some people. It provides a potential mechanism that may be a point of entry for drug therapy.
Read »- jprovins
Navigation
User login
Visit the BiotechMashup Blog
Best upcoming scoops - Medicine
- Memory's master switch
- HDL Interfere with the Binding of T Cell Microparticles to Human Monocytes to Inhibit Pro-Inflammatory Cytokine Production
- UCI immunological study finds earlier way to diagnose axon and neuron degeneration in MS
- Epstein-Barr Virus Interferes with the Amplification of IFNα Secretion by Activating Suppressor of Cytokine Signaling 3 in Prima
- Mutations of Francisella novicida that Alter the Mechanism of Its Phagocytosis by Murine Macrophages